Agency Information Collection Activities; Proposed eCollection; eComments Requested; Extension With or Without Change, of a Previously Approved Collection: Drug Questionnaire (DEA-341), 18483 [2017-07839]

Download as PDF Federal Register / Vol. 82, No. 74 / Wednesday, April 19, 2017 / Notices The United States, on behalf of EPA, has provided the Debtor with a covenant not to sue, under Sections 106 and 107 of CERCLA, with respect to the Facility, as well as a property located adjacent to the Facility (the ‘‘Excluded Area’’), as well as those areas of the Penobscot River where hazardous substances from the Facility or the Excluded Area have come to be located. The covenant also applies to the Debtor’s successors and assigns, former and current officers, directors, employees, and trustees, but only to the extent that the alleged liability of the successor or assign, officer, director, employee, or trustee is based solely on his, her or its status and on his, her or its capacity as a successor or assign, officer, director, employee or trustee of the Debtor. The publication of this notice opens a period for public comment on the Agreement. Comments should be addressed to the Assistant Attorney General, Environment and Natural Resources Division, and should refer to In re: Lincoln Paper and Tissue, LLC, No. 15–10715 PGC, D.J. Ref. No. 90–11– 3–11537. All comments must be submitted no later than thirty (30) days after the publication date of this notice. Comments may be submitted either by email or by mail: To submit comments: Send them to: By email ....... pubcomment-ees.enrd@ usdoj.gov. Assistant Attorney General, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. jstallworth on DSK7TPTVN1PROD with NOTICES By mail ......... During the public comment period, the Agreement may be examined and downloaded at this Justice Department Web site: https://www.justice.gov/enrd/ consent-decrees. We will provide a paper copy of the agreement upon written request and payment of reproduction costs. Please mail your request and payment to: Consent Decree Library, U.S. DOJ—ENRD, P.O. Box 7611, Washington, DC 20044–7611. Please enclose a check or money order for $19.75 (25 cents per page reproduction cost) payable to the United States Treasury. Robert E. Maher, Jr., Assistant Section Chief, Environmental Enforcement Section, Environment and Natural Resources Division. [FR Doc. 2017–07905 Filed 4–18–17; 8:45 am] BILLING CODE 4410–15–P VerDate Sep<11>2014 15:06 Apr 18, 2017 Jkt 241001 DEPARTMENT OF JUSTICE [OMB Number 1117–0043] Agency Information Collection Activities; Proposed eCollection; eComments Requested; Extension With or Without Change, of a Previously Approved Collection: Drug Questionnaire (DEA–341) Drug Enforcement Administration, Department of Justice. ACTION: 30-day notice. AGENCY: Department of Justice (DOJ), Drug Enforcement Administration will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register at 82 FR 15370, on March 28, 2017, allowing for a 60 day comment period. SUMMARY: Comments are encouraged and will be accepted for an additional 30 days until May 19, 2017. FOR FURTHER INFORMATION CONTACT: Written comments and/or suggestions regarding the items contained in this notice, especially the estimated public burden and associated response time, should be directed to Diane E. Filler, Assistant Administrator, Drug Enforcement Administration, Human Resources Division, 8701 Morrissette Drive, Springfield, VA 22152. Written comments and/or suggestions can also be sent to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503 or sent to OIRA_ submissions@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Enhance the quality, utility, and clarity of the information to be collected; and DATES: PO 00000 Frm 00068 Fmt 4703 Sfmt 9990 18483 —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. Overview of This Information Collection (1) Type of Information Collection: Extension of a currently approved collection. (2) Title of the Form/Collection: Drug Questionnaire. (3) Agency form number, if any and the applicable component of the Department sponsoring the collection: The form number is DEA–341. The sponsoring component is the Drug Enforcement Administration. (4) Affected public who will be asked or required to respond, as well as a brief abstract: Primary: Individuals. Other: None. DEA is requesting an extension of a currently approved collection. This collection requires the drug history of any individual seeking employment with DEA. DEA policy states that a past history of illegal drug use may result in ineligibility for employment. The form asks job applicants specific questions about their personal history, if any, of illegal drug use. (5) An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond/reply: It is estimated that 15,000 respondents will complete each form in approximately 5 minutes. (6) An estimate of the total public burden (in hours) associated with the collection: There are an estimated 1,250 total annual burden hours associated with this collection. If additional information is required contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE., Suite 3E.405A, Washington, DC 20530. Dated: April 13, 2017. Melody Braswell, Department Clearance Officer, PRA, U.S. Department of Justice. [FR Doc. 2017–07839 Filed 4–18–17; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\19APN1.SGM 19APN1

Agencies

[Federal Register Volume 82, Number 74 (Wednesday, April 19, 2017)]
[Notices]
[Page 18483]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-07839]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0043]


Agency Information Collection Activities; Proposed eCollection; 
eComments Requested; Extension With or Without Change, of a Previously 
Approved Collection: Drug Questionnaire (DEA-341)

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-day notice.

-----------------------------------------------------------------------

SUMMARY: Department of Justice (DOJ), Drug Enforcement Administration 
will be submitting the following information collection request to the 
Office of Management and Budget (OMB) for review and approval in 
accordance with the Paperwork Reduction Act of 1995. This proposed 
information collection was previously published in the Federal Register 
at 82 FR 15370, on March 28, 2017, allowing for a 60 day comment 
period.

DATES: Comments are encouraged and will be accepted for an additional 
30 days until May 19, 2017.

FOR FURTHER INFORMATION CONTACT: Written comments and/or suggestions 
regarding the items contained in this notice, especially the estimated 
public burden and associated response time, should be directed to Diane 
E. Filler, Assistant Administrator, Drug Enforcement Administration, 
Human Resources Division, 8701 Morrissette Drive, Springfield, VA 
22152. Written comments and/or suggestions can also be sent to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20503 or sent to OIRA_submissions@omb.eop.gov.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be 
collected; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    (1) Type of Information Collection: Extension of a currently 
approved collection.
    (2) Title of the Form/Collection: Drug Questionnaire.
    (3) Agency form number, if any and the applicable component of the 
Department sponsoring the collection: The form number is DEA-341. The 
sponsoring component is the Drug Enforcement Administration.
    (4) Affected public who will be asked or required to respond, as 
well as a brief abstract: Primary: Individuals. Other: None.
    DEA is requesting an extension of a currently approved collection. 
This collection requires the drug history of any individual seeking 
employment with DEA. DEA policy states that a past history of illegal 
drug use may result in ineligibility for employment. The form asks job 
applicants specific questions about their personal history, if any, of 
illegal drug use.
    (5) An estimate of the total number of respondents and the amount 
of time estimated for an average respondent to respond/reply: It is 
estimated that 15,000 respondents will complete each form in 
approximately 5 minutes.
    (6) An estimate of the total public burden (in hours) associated 
with the collection: There are an estimated 1,250 total annual burden 
hours associated with this collection.
    If additional information is required contact: Melody Braswell, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., Suite 3E.405A, Washington, DC 
20530.

    Dated: April 13, 2017.
Melody Braswell,
Department Clearance Officer, PRA, U.S. Department of Justice.
[FR Doc. 2017-07839 Filed 4-18-17; 8:45 am]
 BILLING CODE 4410-09-P